Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M165Revenue $M0.5Net Margin (%)0Z-Score21.3
Enterprise Value $M120EPS $-0.3Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book4.010-y EBITDA Growth Rate %-3.5Quick Ratio19.4Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-15.9Current Ratio19.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-53.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)4ROE % (ttm)-63.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M67.2ROI % (ttm)-93.3Gross Margin Increase y-yN

Gurus Latest Trades with CPRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

CPRX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CPRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MUTH DAVID DExec. V.P., Corp. Development 2014-10-03Buy10,000$2.65-6.42 view
Miller SteveCOO 2014-06-04Buy100,000$2.1714.29 view
MCENANY PATRICK JPresident and CEO 2014-05-21Buy25,000$1.8931.22 view
O'Keeffe Charles BDirector 2014-05-19Buy10,000$1.8335.52 view
O'Keeffe Charles BDirector 2014-04-16Buy5,000$2.0222.77 view
MCENANY PATRICK JPresident and CEO 2014-02-07Buy25,000$1.8236.26 view
O'Keeffe Charles BDirector 2014-02-05Buy10,000$1.8137.02 view
Tierney David SDirector 2013-10-23Buy8,000$2.0322.17 view
O'Keeffe Charles BDirector 2013-10-21Buy10,000$1.8434.78 view
MCENANY PATRICK JPresident and CEO 2013-10-21Buy50,000$1.5955.97 view

Press Releases about CPRX :

    Quarterly/Annual Reports about CPRX:

    News about CPRX:

    Articles On GuruFocus.com
    Largest Insider Buys of the Week Oct 25 2013 
    Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
    Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN Jun 04 2012 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 15 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Aug 12 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 9,359 Shares Jun 16 2010 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) May 17 2010 
    Catalyst Pharmaceutical Partners Inc. (CPRX) CEO Patrick J Mcenany buys 25,000 Shares Nov 16 2009 
    Catalyst Pharmaceutical Partners Inc. Reports Operating Results (10-Q) Nov 12 2009 
    Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results Aug 07 2009 

    More From Other Websites
    Midday Gainers From October 8 - GT Advanced Technologies Inc, Unilife Corp And More Oct 08 2014
    Catalyst Pharmaceuticals to Present Top-Line Safety and Efficacy Results From Phase 3 Firdapse Trial... Oct 08 2014
    Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma Oct 03 2014
    Catalyst Pharmaceuticals to Present at 13th Annual BIO Investor Forum Oct 02 2014
    What Else Is Under the Hood for Catalyst Pharma? Sep 30 2014
    Why Catalyst Pharmaceutical Partners (CPRX) Stock Is Spiking Today Sep 30 2014
    Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug Sep 30 2014
    Ford slips on Europe woes, Cintas, Synnex up on earnings Sep 29 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Sep 29 2014
    Catalyst Pharma's lead drug succeeds in late-stage study Sep 29 2014
    Catalyst Pharmaceuticals Announces Positive Top-Line Phase 3 Data From Pivotal Firdapse Clinical... Sep 29 2014
    Catalyst Pharmaceutical (CPRX) Jumps: Stock Up 9% Sep 05 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Sep 04 2014
    Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development Sep 04 2014
    Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 16th Annual Global Investment... Sep 03 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Sep 02 2014
    Catalyst Pharmaceutical Partners Initiates Phase 1(b) Safety and Tolerance Study for CPP-115 Sep 02 2014
    Why Catalyst Pharmaceutical (CPRX) Could Be Positioned for a Surge? Aug 28 2014
    Your September Biotech Back-to-School Calendar Aug 26 2014
    Catalyst Pharmaceutical Partners (CPRX) Worth Watching: Stock Up 10.3% Aug 26 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Financials Aug 22 2014
    CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Aug 14 2014
    Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee to Continue... Mar 25 2014
    Catalyst Pharmaceutical Partners Announces Fourth Quarter and Year-End 2013 Financial Results and... Mar 19 2014
    Catalyst Pharmaceutical Partners to Present at the 26th Annual ROTH Conference Mar 06 2014
    Catalyst Pharmaceutical Partners Observes Rare Disease Day Today Feb 28 2014
    Catalyst Pharmaceutical Partners to Present at 16th Annual BIO CEO & Investor Conference Feb 06 2014
    Catalyst Pharmaceutical Partners Reports Positive Cardiac Safety Results of Its Phase 3 Product,... Jan 08 2014
    Catalyst Pharmaceutical Partners Reports Dismissal of Stockholder Class Action Lawsuit Jan 07 2014
    Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy... Jan 06 2014
    Catalyst Pharmaceutical Partners Announces Publication of Preclinical Proof-of-Principle of CPP-115... Nov 18 2013
    Catalyst Pharmaceutical Partners Announces Third Quarter 2013 Financial Results Nov 14 2013
    Catalyst Pharmaceutical Announces Social Media Presence Oct 30 2013
    MARKET PULSE- Savient Pharma, Charles Schwab, J.C. Penney, shipping stocks Oct 15 2013

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK